8 Best Synthego Alternatives & Competitors (2026)

Twist Bioscience is a leader in synthetic DNA production using a silicon platform for high-throughput oligo and gene synthesis. It excels in scale and speed for many applications in drug discovery and data storage. Compared to Ansa Biotechnologies' enzymatic approach, Twist may offer more established pricing models and broader catalog but potentially shorter max lengths or different accuracy profiles for very long constructs.

IDT provides custom oligos and genes via chemical synthesis with fast online ordering and academic pricing. It is widely used for standard molecular biology needs. Versus Ansa, IDT offers quicker access for shorter sequences but may require more post-processing for very long or complex DNA compared to enzymatic methods.

GenScript delivers gene synthesis, protein services and custom DNA with global labs and competitive turnaround. Strengths include one-stop biotech services. In comparison to Ansa Biotechnologies, GenScript uses traditional methods that can be more accessible for routine orders but less optimized for ultra-long enzymatic DNA production.

Eurofins Genomics supplies DNA sequencing and synthesis services with strong European presence and volume capabilities. It suits large-scale projects. Relative to Ansa, it relies on established chemical processes offering reliable but potentially less innovative long-strand synthesis options.

Codex DNA focuses on automated benchtop gene synthesis systems for synthetic biology labs. It enables on-site production. Compared to Ansa Biotechnologies enzymatic platform, Codex provides hardware solutions that may reduce outsourcing but with different throughput and length capabilities.

Thermo Fisher offers GeneArt synthesis services alongside broad life science tools. It is convenient for integrated lab workflows. Against Ansa, it provides chemical synthesis with extensive support infrastructure but may not match specialized enzymatic advantages for complex DNA.

ATUM specializes in DNA design and synthesis with AI-driven sequence optimization. It targets protein expression projects. In contrast to Ansa Biotechnologies, ATUM emphasizes design tools paired with synthesis that can complement or compete depending on project scale and length needs.